These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8069961)
1. Structure-activity relationship study of 6-O-methylerythromycin 9-O-substituted oxime derivatives. Kawashima Y; Yamada Y; Asaka T; Misawa Y; Kashimura M; Morimoto S; Ono T; Nagate T; Hatayama K; Hirono S Chem Pharm Bull (Tokyo); 1994 May; 42(5):1088-95. PubMed ID: 8069961 [TBL] [Abstract][Full Text] [Related]
2. Studies on macrolide antibiotics I. Synthesis and antibacterial activity of erythromycin A 9-O-substituted oxime ether derivatives against Mycobacterium avium complex. Nishimoto A; Narita K; Ohmoto S; Takahashi Y; Yoshizumi S; Yoshida T; Kado N; Okezaki E; Kato H Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1120-7. PubMed ID: 11558597 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A. Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668 [TBL] [Abstract][Full Text] [Related]
4. [Synthesis and antibacterial activity of 3-hydroxy-6-O-methylerythromycin-9-O-substituted oxime derivatives]. Chen SX; Xu XD; Yu LX Yao Xue Xue Bao; 2001 Aug; 36(8):581-4. PubMed ID: 12579933 [TBL] [Abstract][Full Text] [Related]
5. The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12. Liu ML; Pan XY; Yang T; Zhang WM; Wang TQ; Wang HY; Lin HX; Yang CG; Cui YM Bioorg Med Chem Lett; 2016 Nov; 26(22):5492-5496. PubMed ID: 27777007 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics. Tanikawa T; Asaka T; Kashimura M; Misawa Y; Suzuki K; Sato M; Kameo K; Morimoto S; Nishida A J Med Chem; 2001 Nov; 44(24):4027-30. PubMed ID: 11708904 [TBL] [Abstract][Full Text] [Related]
7. 9-Oxime-3-ketolides: modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens. Nomura T; Yasukata T; Narukawa Y; Uotani K Bioorg Med Chem; 2005 Nov; 13(21):6054-63. PubMed ID: 15994088 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of novel 3-O-arylalkylcarbamoyl-3-O-descladinosyl-9-O-(2-chlorobenzyl)oxime clarithromycin derivatives. Qin Y; Qiang S; Ji S; Liu Z; Hu C; Ma S Bioorg Med Chem Lett; 2018 Nov; 28(20):3324-3328. PubMed ID: 30219527 [TBL] [Abstract][Full Text] [Related]
9. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891 [TBL] [Abstract][Full Text] [Related]
10. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890 [TBL] [Abstract][Full Text] [Related]
11. 3-Keto-11,12-carbazate derivatives of 6-O-methylerythromycin A synthesis and in vitro activity. Griesgraber G; Or YS; Chu DT; Nilius AM; Johnson PM; Flamm RK; Henry RF; Plattner JJ J Antibiot (Tokyo); 1996 May; 49(5):465-77. PubMed ID: 8682724 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of two and antibacterial activity of one novel oxime ether derivatives of erythromycin A. Dondas HA; Yaktubay N Farmaco; 2003 Oct; 58(10):1011-5. PubMed ID: 14505731 [TBL] [Abstract][Full Text] [Related]
13. Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials. Pavlović D; Fajdetić A; Mutak S Bioorg Med Chem; 2010 Dec; 18(24):8566-82. PubMed ID: 21055953 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial evaluation of (E)-1-(1H-indol-3-yl) ethanone O-benzyl oxime derivatives against MRSA and VRSA strains. Akunuri R; Veerareddy V; Kaul G; Akhir A; Unnissa T; Parupalli R; Madhavi YV; Chopra S; Nanduri S Bioorg Chem; 2021 Nov; 116():105288. PubMed ID: 34454299 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens. Ma CX; Lv W; Li YX; Fan BZ; Han X; Kong FS; Tian JC; Cushman M; Liang JH Eur J Med Chem; 2019 May; 169():1-20. PubMed ID: 30852383 [TBL] [Abstract][Full Text] [Related]
16. 3-Keto-9-O-substituted oxime derivatives of 6-O-methyl erythromycin A synthesis and in vitro activity. Shengxi C; Xiandong X; Lanxiang Y J Antibiot (Tokyo); 2001 Jun; 54(6):506-9. PubMed ID: 11513040 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of novel 4''-O-carbamoyl erythromycin-A derivatives. Qi Y; Jiao B; Ma X; Cui W; Ma S Arch Pharm (Weinheim); 2010 Aug; 343(8):458-64. PubMed ID: 20803622 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes. Tang D; Gai Y; Polemeropoulos A; Chen Z; Wang Z; Or YS Bioorg Med Chem Lett; 2008 Sep; 18(18):5078-82. PubMed ID: 18762418 [TBL] [Abstract][Full Text] [Related]
19. The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid. Zhang WM; Yao Y; Yang T; Wang XY; Zhu ZY; Xu WT; Lin HX; Gao ZB; Zhou H; Yang CG; Cui YM Bioorg Med Chem Lett; 2018 Jun; 28(10):1943-1948. PubMed ID: 29650291 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimicrobial activity of erythromycin-A oxime analogs. Pandey D; Katti SB; Haq W; Tripathi CK Bioorg Med Chem; 2004 Jul; 12(14):3807-13. PubMed ID: 15210147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]